Sandra Wagner Cardoso, MD, MSc
Sandra Wagner Cardoso, MD, MSc (Faculty Mentor) is Clinical Director of the Fiocruz CTU and has contributed as Site Investigator and Protocol Team member to multiple ACTG research studies, as well as investigator-initiated clinical research studies at Fiocruz. Within the ACTG, she is a Member of the Bone Complications Working Group as well as the Hepatitis Transformative Science Group.
Epidemiology of HIV and STIs
Clinical management of HIV infection and associated complications
Cardoso SW, Grinsztejn B, Velasque L, Veloso VG, Luz PM, Friedman RK, Morgado M, Ribeiro SR, Moreira RI, Keruly J, Moore RD. Incidence of Modifying or Discontinuing First HAART Regimen and Its Determinants in a Cohort of HIV-infected Patients from Rio de Janeiro, Brazil. AIDS Res Hum Retro. August 2010, 26 (8) :865 -74.
Cardoso SW, Luz PM, Velasque L, Torres T, Coelho L, Freedberg KA, Veloso VG, Walensky RP, Grinsztejn B. Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil. AIDS Res Ther. 2014 Sep 1;11:29. eCollection 2014.
Cardoso SW, Luz PM, Velasque L, Torres TS, Tavares IC, Ribeiro SR, Moreira RI, Veloso VG, Moore RD, Grinsztejn B. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. BMC Infect Dis. 2014 Dec 19;14:699.
Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa A, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A; New Work Concept Sheet 319 and The Prospective Evaluation of Antiretrovirals in Resource-Limited Settings Study Team. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis. 2015 Mar 31. pii: civ265.
Applications for the 2026-27 Fellowship class are now being accepted and will be reviewed on a rolling basis.